In the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Kidney Cancer that appeared in the September issue of JNCCN (JNCCN 2011;9:960-977), an error appears in the Targeted Therapy section on page 970. The second sentence of the second paragraph should have read, “The most widely used model for risk stratification is the MSKCC model,46 which classifies patients according the presence or absence of 5 adverse prognostic factors: Karnofsky performance status of 70 or less, serum LDH level greater than 1.5 times the upper limit of normal (ULN), hemoglobin level below normal, corrected serum calcium level above the ULN, and time from diagnosis and nephrectomy to therapy of less than 1 year.”

These NCCN Guidelines have been corrected online at and in the September issue of JNCCN available online at

If the inline PDF is not rendering correctly, you can download the PDF file here.

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 6 2 0
PDF Downloads 1 1 0
EPUB Downloads 0 0 0